314 related articles for article (PubMed ID: 15262739)
21. Imaging correlates of axonal swelling in chronic multiple sclerosis brains.
Fisher E; Chang A; Fox RJ; Tkach JA; Svarovsky T; Nakamura K; Rudick RA; Trapp BD
Ann Neurol; 2007 Sep; 62(3):219-28. PubMed ID: 17427920
[TBL] [Abstract][Full Text] [Related]
22. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M
Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256
[TBL] [Abstract][Full Text] [Related]
23. Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis.
Gadea M; Martínez-Bisbal MC; Marti-Bonmatí L; Espert R; Casanova B; Coret F; Celda B
Brain; 2004 Jan; 127(Pt 1):89-98. PubMed ID: 14506072
[TBL] [Abstract][Full Text] [Related]
24. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease.
Vrenken H; Pouwels PJ; Ropele S; Knol DL; Geurts JJ; Polman CH; Barkhof F; Castelijns JA
Mult Scler; 2007 Jul; 13(6):708-16. PubMed ID: 17613597
[TBL] [Abstract][Full Text] [Related]
25. Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under high-dose methylprednisolone therapy.
Schocke MF; Berger T; Felber SR; Wolf C; Deisenhammer F; Kremser C; Seppi K; Aichner FT
Neuroimage; 2003 Oct; 20(2):1253-63. PubMed ID: 14568494
[TBL] [Abstract][Full Text] [Related]
26. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.
He J; Inglese M; Li BS; Babb JS; Grossman RI; Gonen O
Radiology; 2005 Jan; 234(1):211-7. PubMed ID: 15528260
[TBL] [Abstract][Full Text] [Related]
27. White matter changes in multiple sclerosis: correlation of q-space diffusion MRI and 1H MRS.
Assaf Y; Chapman J; Ben-Bashat D; Hendler T; Segev Y; Korczyn AD; Graif M; Cohen Y
Magn Reson Imaging; 2005 Jul; 23(6):703-10. PubMed ID: 16198825
[TBL] [Abstract][Full Text] [Related]
28. Prospective longitudinal proton magnetic resonance spectroscopic imaging in adult traumatic brain injury.
Holshouser BA; Tong KA; Ashwal S; Oyoyo U; Ghamsary M; Saunders D; Shutter L
J Magn Reson Imaging; 2006 Jul; 24(1):33-40. PubMed ID: 16755529
[TBL] [Abstract][Full Text] [Related]
29. [Value of magnetization transfer imaging in judging microchanges lesions in normal-appearing white matter of multiple sclerosis].
Chu SG; Shen TZ; Chen XR
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1181-5. PubMed ID: 15387980
[TBL] [Abstract][Full Text] [Related]
30. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
[TBL] [Abstract][Full Text] [Related]
31. Quantitative proton magnetic resonance spectroscopic imaging: regional variations in the corpus callosum and cortical gray matter.
Degaonkar MN; Pomper MG; Barker PB
J Magn Reson Imaging; 2005 Aug; 22(2):175-9. PubMed ID: 16028259
[TBL] [Abstract][Full Text] [Related]
32. The relationship between diffuse axonal damage and fatigue in multiple sclerosis.
Tartaglia MC; Narayanan S; Francis SJ; Santos AC; De Stefano N; Lapierre Y; Arnold DL
Arch Neurol; 2004 Feb; 61(2):201-7. PubMed ID: 14967766
[TBL] [Abstract][Full Text] [Related]
33. A magnetization transfer MRI study of deep gray matter involvement in multiple sclerosis.
Sharma J; Zivadinov R; Jaisani Z; Fabiano AJ; Singh B; Horsfield MA; Bakshi R
J Neuroimaging; 2006 Oct; 16(4):302-10. PubMed ID: 17032378
[TBL] [Abstract][Full Text] [Related]
34. T1 relaxation time mapping of white matter tracts in multiple sclerosis defined by diffusion tensor imaging.
Vaithianathar L; Tench CR; Morgan PS; Wilson M; Blumhardt LD
J Neurol; 2002 Sep; 249(9):1272-8. PubMed ID: 12242553
[TBL] [Abstract][Full Text] [Related]
35. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
Benedetti B; Rovaris M; Rocca MA; Caputo D; Zaffaroni M; Capra R; Bertolotto A; Martinelli V; Comi G; Filippi M
Mult Scler; 2009 Jul; 15(7):789-94. PubMed ID: 19465450
[TBL] [Abstract][Full Text] [Related]
36. Imaging axonal damage of normal-appearing white matter in multiple sclerosis.
Fu L; Matthews PM; De Stefano N; Worsley KJ; Narayanan S; Francis GS; Antel JP; Wolfson C; Arnold DL
Brain; 1998 Jan; 121 ( Pt 1)():103-13. PubMed ID: 9549491
[TBL] [Abstract][Full Text] [Related]
37. Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome.
Stromillo ML; Giorgio A; Rossi F; Battaglini M; Hakiki B; Malentacchi G; Santangelo M; Gasperini C; Bartolozzi ML; Portaccio E; Amato MP; De Stefano N
Neurology; 2013 Jun; 80(23):2090-4. PubMed ID: 23635962
[TBL] [Abstract][Full Text] [Related]
38. Proton MR spectroscopy to assess axonal damage in multiple sclerosis and other white matter disorders.
De Stefano N; Narayanan S; Matthews PM; Mortilla M; Dotti MT; Federico A; Arnold DL
J Neurovirol; 2000 May; 6 Suppl 2():S121-9. PubMed ID: 10871799
[TBL] [Abstract][Full Text] [Related]
39. Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis.
Gallo A; Rovaris M; Riva R; Ghezzi A; Benedetti B; Martinelli V; Falini A; Comi G; Filippi M
Arch Neurol; 2005 May; 62(5):803-8. PubMed ID: 15883269
[TBL] [Abstract][Full Text] [Related]
40. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis.
Inglese M; Li BS; Rusinek H; Babb JS; Grossman RI; Gonen O
Magn Reson Med; 2003 Jul; 50(1):190-5. PubMed ID: 12815694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
